Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9098 |
High Similarity |
NPD3027 |
Phase 3 |
0.9037 |
High Similarity |
NPD1613 |
Approved |
0.9037 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8881 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8806 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8529 |
High Similarity |
NPD2861 |
Phase 2 |
0.8467 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8358 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8345 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD1934 |
Approved |
0.817 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8079 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8077 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8065 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.806 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8052 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7971 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7955 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7911 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7887 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7871 |
Intermediate Similarity |
NPD37 |
Approved |
0.7862 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7847 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7842 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7842 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.784 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7834 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7834 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7834 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7832 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7803 |
Intermediate Similarity |
NPD228 |
Approved |
0.777 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7764 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7724 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7704 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7698 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7697 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7683 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7667 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7652 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7652 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7636 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7603 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7597 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7589 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7571 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7566 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7552 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7535 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.753 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4678 |
Approved |
0.75 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7465 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7445 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7444 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7424 |
Intermediate Similarity |
NPD968 |
Approved |
0.7417 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7417 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7417 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7413 |
Intermediate Similarity |
NPD8651 |
Approved |
0.74 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7386 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7386 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7375 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD290 |
Approved |
0.7357 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7355 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7353 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7351 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7338 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7329 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7326 |
Intermediate Similarity |
NPD4663 |
Approved |
0.732 |
Intermediate Similarity |
NPD4237 |
Approved |
0.732 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.732 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7315 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7315 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7308 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7303 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7289 |
Intermediate Similarity |
NPD27 |
Approved |
0.7285 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7267 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7259 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7255 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7251 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7251 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7248 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7229 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7229 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7222 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7212 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7209 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7209 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7208 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7197 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7192 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7171 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7169 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7169 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7162 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7161 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7161 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD2978 |
Approved |
0.716 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7126 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7124 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7121 |
Intermediate Similarity |
NPD846 |
Approved |
0.7121 |
Intermediate Similarity |
NPD940 |
Approved |
0.7115 |
Intermediate Similarity |
NPD6190 |
Approved |
0.711 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7099 |
Intermediate Similarity |
NPD3383 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3384 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7095 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7081 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7078
|
Intermediate Similarity |
NPD6005 |
Phase 3 |